Two Sigma Securities’s Lucid Diagnostics LUCD Stock Holding History

Two Sigma Securities’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,601	Closed	-$12.6K	–	1960
2025 Q4	$12.6K	Buy	+11,601	New	+$13K	﹤0.01%	1259
2025 Q1	–	Sell	-19,316	Closed	-$15.8K	–	1888
2024 Q4	$15.8K	Buy	+19,316	New	+$17K	﹤0.01%	1357
2024 Q3	–	Sell	-27,753	Closed	-$22.8K	–	3319
2024 Q2	$22.8K	Buy	+27,753	New	+$23.5K	﹤0.01%	2676

Other funds holding LUCD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Two Sigma Securities's LUCD Position: Q1 2026 in Review

Two Sigma Securities sold out of Lucid Diagnostics (LUCD) in Q1 2026, closing a stake of 11,601 shares — an estimated $12.6K sold.

Two Sigma Securities first reported a position in LUCD in Q2 2024 and held it in 3 quarters. The position peaked at $22.8K in Q2 2024. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

Two Sigma Securities reported no remaining Lucid Diagnostics position as of Q1 2026 after selling out during the quarter.
Two Sigma Securities sold 11,601 Lucid Diagnostics shares in Q1 2026, an estimated $12.6K.
Two Sigma Securities first reported a position in Lucid Diagnostics in Q2 2024 and held it in 3 quarters.
Two Sigma Securities's Lucid Diagnostics position peaked at $22.8K in Q2 2024.
103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.